Human serum albumin (HSA) has been indicated for the treatment of several conditions, including shock, blood volume resuscitation, and hypoalbuminemia, in the past three decades with optimal safety and efficacy profiles in humans [17-18]. The gene discussed is ALB; the disease is Hypoalbuminemia.